ERBB2 and breast carcinoma: With the application of traditional biomarkers, including estrogen hormone receptors (ER) [2], progesterone receptor (PR) [3], and human epidermal growth factor receptor-2 (HER2) [4], numerous promising advances concerning the breast cancer therapy are reported.